In conclusion, our results indicate that the hFSP1-specific inhibitor icFSP1 may trigger phase separation of FSP1 and synergize with canonical ferroptosis inhibitors to induce ferroptosis, as a viable way for efficient eradication of certain cancer entities. This evidence concerns the gene AIFM2 and cancer.